Date Range
toReport Types
Condition
See all (67)
Region of the Body
See all (21)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Arthroscopy. 2014 Aug;30(8):987-96
Asymptomatic DVT reduced, no reduction in symptomatic VTE with LMWH vs control in knee arthroscopy
PLoS One. 2018 Jun 21;13(6):e0197868
Routine thromboprophylaxis appears unnecessary following knee arthroscopy and lower-leg casting
N Engl J Med. 2017 Feb 9;376(6):515-525.
Portable compression device in addition to LMWH lowers DVT rate after TKA
J Arthroplasty. 2008 Dec;23(8):1122-7. Epub 2008 Apr 2
THA: Heparin does not stop pelvic thrombi but may prevent ipsilateral femoral thrombi
J Arthroplasty. 2005 Jan;20(1):42-50
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
J Bone Joint Surg Am. 2010 Mar;92(3):527-35
Major orthopedic surgery: Low-molecular-weight heparins vs other anticoagulants
Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
PloS one. 2020 Aug-03;():. 10.1371/journal.pone.0235628
Low-molecular-weight heparin prophylaxis may reduce DVT incidence after knee arthroscopy
Arthroscopy. 2014 Mar;30(3):406-12. doi: 10.1016/j.arthro.2013.12.021.
Delayed LMWH lowers bleeding while maintaining DVT prophylaxis in TKA
Arch Orthop Trauma Surg. 2014 May;134(5):679-83. doi: 10.1007/s00402-014-1939-2. Epub 2014 Feb 18
TKA prophylaxis: Risk-dependent anticoagulation safer than routine anticoagulation
J Arthroplasty. 2013 Dec;28(10):1868-73. doi: 10.1016/j.arth.2013.05.025. Epub 2013 Jun 21.
Preventing Venous Thromboembolism after THA
JAMA. 1994: 271(22): 1780-1785.
Extended thromboprophylaxis with aspirin noninferior to dalteparin for THA patients
Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004
Oral anticoagulants/LMW heparins provide comparable safety in antithrombotic prophylaxis
Semin Thromb Hemost. 2016 Feb;42(1):42-54